These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7940899)

  • 1. Soluble IL-2R assay and spontaneous blastogenesis in the immunological monitoring of kidney transplant patients.
    de Boccardo G; Albano S; Alvarellos T; Massari P; Giraudo C
    Transplant Proc; 1994 Oct; 26(5):2854-6. PubMed ID: 7940899
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical relevance of pretransplant recipient immunoresponsiveness in renal transplantation: impact on rejection.
    Renna Molajoni E; Cinti P; Evangelista B; Poli L; Cocciolo P; Berloco P; Cortesini R
    Transplant Proc; 1996 Feb; 28(1):402-3. PubMed ID: 8644290
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapamycin in a porcine renal transplant model.
    Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
    [No Abstract]   [Full Text] [Related]  

  • 4. Soluble interleukin-2 receptor (sIL-2R) levels in renal transplantation: comparison between clinical and laboratory analysis.
    Montagnino G; Tarantino A; Grignani S; Braga M; Ponticelli C
    Clin Transplant; 1995 Feb; 9(1):25-30. PubMed ID: 7742579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum immunological parameters in acute renal allograft rejection.
    Yang J; Li XW; Zheng FL; Bi ZQ
    Transplant Proc; 1996 Jun; 28(3):1443-4. PubMed ID: 8658732
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyridoxal-5' -phosphate stimulation of aminotransferase activities in serum of hemodialysis patients and renal-transplant recipients.
    Jung K
    Clin Nephrol; 1996 Jun; 45(6):416-7. PubMed ID: 8793238
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin-2 receptor as an immunodiagnostic tool to differentiate rejection from nephrotoxicity.
    Smith AY; Citterio F; Welsh M; Kerman RH; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1462-4. PubMed ID: 2652467
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.
    Løkkegaard H; Asmundsson P; Clausen P; Dieperink H; Hansen JM; Heaf J; Jensen SB; Kornerup HJ; Madsen S; Pedersen EB; Poulsen JV; Rasmussen K
    Transplant Proc; 1996 Aug; 28(4):2199-201. PubMed ID: 8769199
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha/beta, gamma/delta T cells and interleukin-2 receptor chain expression in kidney graft recipients under triple-drug immunosuppression.
    Zezina L; Kirman I; Rosental R
    Transplant Proc; 1994 Oct; 26(5):2868. PubMed ID: 7940905
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of acute renal transplant rejection with FK 506 in patients on cyclosporine after failure of standard antirejection therapy.
    Scott-Douglas N; Zimmerman D; Klassen J
    Transplant Proc; 1996 Dec; 28(6):3165. PubMed ID: 8962226
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of different anti-rejection regimens on the expression of differentiation and activation markers on the surface of host lymphocytes.
    Malinowski K; Ye H; Waltzer WC
    Transplant Proc; 2000 Jun; 32(4):773-5. PubMed ID: 10856579
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of anti CD45 on different immunosuppressive regimes in renal transplantation.
    Talbot D; Shenton BK; Bell A; White M; Glennon A; Manas D; Minford E; Rix D; Mathew A; Kumar A; Taylor RM
    Transplant Proc; 1996 Dec; 28(6):3212-3. PubMed ID: 8999605
    [No Abstract]   [Full Text] [Related]  

  • 13. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H; Otte B; Lang D; Heidenreich S
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum C-reactive protein: a useful, economical marker of immune activation in cadaveric renal transplantation.
    Harris KR; Digard NJ; Slapak M; Lee HA
    Transplant Proc; 1995 Feb; 27(1):1046-7. PubMed ID: 7878797
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic rejection of renal allografts with four immunosuppressive regimens.
    Isoniemi H; Ahonen J; Krogerus L; Eklund B; Höckerstedt K; Salmela K; Häyry P
    Transplant Proc; 1992 Dec; 24(6):2716-7. PubMed ID: 1465912
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract]   [Full Text] [Related]  

  • 18. BT563 significantly decreases sIL-2R plasma levels despite acute allograft rejection.
    Mueller AR; Platz KP; Steinmüller T; Nüssler N; Neumann U; Gerlach H; Stoll C; Bechstein WO; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3103-5. PubMed ID: 8962203
    [No Abstract]   [Full Text] [Related]  

  • 19. Triple therapy with cyclosporine A in kidney transplant patients.
    Matl I; Jirka J; Petrásek R; Vítko S
    Transplant Proc; 1995 Oct; 27(5):2573. PubMed ID: 7482831
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring of renal transplant patients with interleukin-2 and interleukin-2 receptor enzyme immunoassay and interleukin-2 receptor immunocytology.
    Dittmer R; Harfmann P; Tenschert W; Arndt R; Busch B
    Transplant Proc; 1990 Oct; 22(5):2284-5. PubMed ID: 2219370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.